News | Proton Therapy | April 28, 2017

IBA Installs Three Proteus One Systems in One Week

Centers in the U.K., France and Japan now have access to intensity modulated proton therapy

IBA Installs Three Proteus One Systems in One Week

April 28, 2017 — IBA announced the delivery and rigging of three Proteus One treatment rooms in less than a week at centers in three different countries in early April. The centers include The Rutherford Cancer Centre, South Wales, United Kingdom); Cyclhad (Cyclotron for Hadron Therapy) located in Caen, France; and Hokkaido Ohno Memorial Hospital located in Sapporo, Japan.

All three centers will be equipped with IBA’s compact Proteus One solution, comprising the latest technology of image guided, intensity modulated proton therapy. Being able to ship and rig three compact proton therapy solutions in less than a week is a world first, according to IBA.

For more information: www.iba-worldwide.com

Related Content

Liver cancer tumor scanning using an MRI
News | Proton Therapy | November 04, 2019
November 4, 2019 – Two new studies support and inform the use of proton radiation therapy to treat patients with hepa
Advanced Radiation Therapy Upgrades AccuBoost Digital Brachytherapy Platform
News | Brachytherapy Systems, Women's Healthcare | October 23, 2019
At the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, Sept. 15-18 in Chicago, Advanced Radiation...
MD Anderson and Varian Partner to Optimize Radiation Oncology Treatment
News | Treatment Planning | October 18, 2019
The University of Texas MD Anderson Cancer Center and Varian announced a new strategic collaboration to develop an...
Videos | Radiation Oncology | October 11, 2019
Lorraine Drapek, DNP, nurse practitioner, radiation oncology, GI service,...
Patient Treatments With ViewRay's MRIdian Linac Begin in New England
News | Image Guided Radiation Therapy (IGRT) | October 08, 2019
ViewRay Inc. announced today that patient treatments are scheduled to begin in Boston with ViewRay's MRIdian Linac...
ProTom International received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Radiance 330 proton therapy system
News | Proton Therapy | October 07, 2019
ProTom International received 510(k) clearance from the U.S.